Job Watch

NCCIH Policy for Submission of Parent R01 Applications Proposing Clinical Trials

Notice NOT-AT-17-006 from the NIH Guide for Grants and Contracts

Genetics Project Manager - Wuxi NextCODE - Cambridge, MA

Indeed.com - Bioinformatics - Wed, 2017-03-29 07:41
Assist our VP Operations & Project Management to support our Biotech & Pharmaceutical project customers with next generation sequencing, database architecture,...
From Indeed - Wed, 29 Mar 2017 11:41:31 GMT - View all Cambridge jobs
Categories: Job Watch

Senior Computational Scientist (Deep Learning) - Wuxi NextCODE - Cambridge, MA

Indeed.com - Bioinformatics - Wed, 2017-03-29 07:36
Ideal candidate will be a software engineer or computational biologist that can think from the point of view of a biologist while understanding computer science...
From Indeed - Wed, 29 Mar 2017 11:36:57 GMT - View all Cambridge jobs
Categories: Job Watch

Cleared Software Developer - Reston, VA - Orbis Technologies - Reston, VA

Indeed.com - Bioinformatics - Wed, 2017-03-29 07:34
BS or Advanced degree in Computer Engineering, Computer Science, or closely related technical area (Math, Bioinformatics, other Engineering)....
From Orbis Technologies - Wed, 29 Mar 2017 11:34:55 GMT - View all Reston jobs
Categories: Job Watch

Biomolecular Engineering: Stem Cell Bioinformatician - University of California, Santa Cruz - Santa Cruz, CA

Indeed.com - Bioinformatics - Wed, 2017-03-29 06:27
By assisting with analysis and interpretation of published data; BA/BS in Bioinformatics or related field with 1 year of post-baccalaureate research experience...
From University of California, Santa Cruz - Wed, 29 Mar 2017 10:27:35 GMT - View all Santa Cruz jobs
Categories: Job Watch

Mechanisms and Consequences of Sleep Disparities in the U.S. (R21)

Funding Opportunity PAR-17-235 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote exploratory and developmental research to understand the underlying mechanisms of sleep deficiencies among health disparity populations and how sleep deficiencies may lead to disparities in health outcomes.

Mechanisms and Consequences of Sleep Disparities in the U.S. (R01)

Funding Opportunity PAR-17-234 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to promote research to understand the underlying mechanisms of sleep deficiencies among health disparity populations and how sleep deficiencies may lead to disparities in health outcomes.

Healthcare & Life Sciences - Data Scientist - KPMG - Atlanta, GA

Indeed.com - Bioinformatics - Wed, 2017-03-29 04:28
Analyze and model structured data and implement algorithms to support analysis using advanced statistical and mathematical methods from statistics, machine...
From KPMG LLP - Wed, 29 Mar 2017 08:28:26 GMT - View all Atlanta jobs
Categories: Job Watch

Revision: Notice to Extend PA-14-290 and PA-14-291

Notice NOT-HS-17-011 from the NIH Guide for Grants and Contracts

Genetic Susceptibility and Variability of Human Structural Birth Defects (R01)

Funding Opportunity PAR-17-236 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support innovative applications that will inform our understanding of structural birth defects through the use of animal models in conjunction with translational/clinical approaches. Applicants are encouraged to take advantage of advances in genetics, biochemistry, molecular, and developmental biology to identify specific genetic, epigenetic, environmental, or gene/environment interactions associated with the susceptibility to and variability of structural birth defects in human populations. Applicants funded through this FOA will join the NICHD Birth Defects Working Group and participate in annual meetings designed to provide a forum to discuss research progress, exchange ideas, share resources, and foster collaborations relevant to the goals of the NICHD's Birth Defects Initiative.

Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R43)

Funding Opportunity PAR-17-199 from the NIH Guide for Grants and Contracts. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes within the National Institutes of Health (NIH) encourage small business SBIR grant applications to address different and complementary research needs for the development of appropriate pediatric drug formulations in different age groups. This FOA also encourages the development and testing of novel drug delivery systems in the pediatric population. The goal of this FOA is to complement and accelerate the development of appropriate pediatric drugs formulations and drug delivery systems.

Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R41)

Funding Opportunity PAR-17-200 from the NIH Guide for Grants and Contracts. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and participating Institutes within the National Institutes of Health (NIH) encourage small business grant applications to address different and complementary research needs for the development appropriate pediatric drug formulations in different age groups. This FOA also encourages the development and testing of novel drug delivery systems in the pediatric population. The goal of this FOA is to complement and accelerate the development of appropriate pediatric drugs formulations and drug delivery systems.

Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R21)

Funding Opportunity PAR-17-192 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. This FOA also encourages the development of novel drug delivery systems in the pediatric population. Investigators are encouraged to explore approaches and concepts new to the area of pediatric formulation development and testing and use newly developed techniques superior to the ones currently used in the field. Applications submitted under this mechanism should be exploratory and novel.

Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R03)

Funding Opportunity PAR-17-191 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. This FOA also encourages the development of novel drug delivery systems in the pediatric population. Investigators are encouraged to explore approaches and concepts new to the area of pediatric formulation development and testing and use newly developed techniques superior to the ones currently used in the field. This FOA supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding.

Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R01)

Funding Opportunity PAR-17-193 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages grant applications to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. Development and testing of novel pediatric drug delivery systems is also part of this initiative.

Pages

Subscribe to Anil Jegga aggregator - Job Watch